Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

THERAPEUTIC AGENT AND THERAPEUTIC METHOD WHICH ARE FOR CANCER PATIENTS EXHIBITING RB1…

Application WO-2024048687-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.